COVID-19: Safety and Immunogenicity of a Reduced Dose of the BioNTech/Pfizer BNT162b2 Vaccine

计划入组 145 人 · 首次发布于 2021 年 4 月 21 日

Role of Vit-D Supplementation on BioNTech, Pfizer Vaccine Side Effect and Immunoglobulin G Response

计划入组 500 人 · 首次发布于 2023 年 5 月 9 日

Pfizer-BioNTech COVID-19 Vaccine Effectiveness Study - Kaiser Permanente Southern California

计划入组 1 人 · 首次发布于 2021 年 4 月 19 日

Bivalent influenza modRNA vaccine(BioNTech/Pfizer)

PF-07926307

Monovalent influenza modRNA vaccine (BioNTech/Pfizer)

BioNTech SE

Germany

Pfizer SA

Venezuela

BioNTech Diagnostics GmbH

Germany

EU Postpones Decision on BioNTech-Pfizer Vaccine Approval

GSK's mRNA Patent Showdown Against Moderna, BioNTech and Pfizer Opens at The Hague UPC

Moderna and Pfizer/BioNTech Locked in Escalating mRNA Patent Battle with Billions at Stake